Ratings Image Scan Holdings Plc

Equities

IGE

GB0031410581

Delayed London S.E. Other stock markets 07:17:34 08/05/2024 pm IST			5-day change	1st Jan Change
1.23 ^GBX	-8.89%		-10.55%	-27.65%

30/04	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN
30/04	Earnings Flash (IGE.L) IMAGE SCAN HOLDINGS Posts fiscal H1 Revenue GBP1.1M	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
Thanks to a sound financial situation, the firm has significant leeway for investment.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.23 for the 2024 fiscal year.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

	1st Jan change	Capi.	ESG Refinitiv
IMAGE SCAN HOLDINGS PLC	-27.65%	2.32M	-
THERMO FISHER SCIENTIFIC	+8.19%	219B	B
DANAHER CORPORATION	+7.78%	184B	B-
INTUITIVE SURGICAL, INC.	+13.19%	138B	B-
SIEMENS HEALTHINEERS AG	-1.18%	62.54B	A-
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.23%	52.22B	B+
EDWARDS LIFESCIENCES CORPORATION	+12.12%	51.73B	B+
AGILENT TECHNOLOGIES, INC.	+2.25%	41.4B	A
GE HEALTHCARE TECHNOLOGIES INC.	+3.83%	37.17B	-
RESMED, INC.	+23.19%	31.76B	B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes